District Court The Hague, 22 December 2010, case- /docketno. 346123 / HA ZA 09-2871, Janssen Pharmaceutica N.V. v Pharmachemie B.V. and Mosadex C.V. (Interim judgment)
This case concerns the patent of Janssen for a pharmaceutical composition comprising a compound of a specified formula and a blood pressure reducing agent (claim 4 of the patent). Pharmachemie markets a product containing nebivolol. Nebivolol consists of l-nebivolol (or: RSSS) which is the specified compound, and d-nebivolol, which is the other compound (or: SRRR) and is specified in claim 6 (dependent on claim 4) of the patent.